Etubics

Etubics Corporation is a Seattle-based biopharmaceutical company developing targeted immunotherapies and vaccine products for various elastic diseases. Compared with existing vector vaccines and gene delivery platforms, Etubics' patented technology has been proven to be safer, more effective, and more efficient.